Traws Pharma, Inc. (TRAW) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Traws Pharma, Inc. (TRAW) closed at USD 0.40 on 2026-10-14, a change of -84.4 % over the past year, with a market capitalization of USD 6.19M.

Traws Pharma, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Traws Pharma, Inc. key figures

Previous close

USD 0.40 (2026-10-14)

1-year change

-84.4 %

Market cap

USD 6.19M

Enterprise value

USD 1.18M

P/E ratio (trailing)

-0.24

P/E ratio (forward)

-0.21

EPS (trailing)

-1.71

EPS (forward)

-1.88

PEG ratio

n/a

Price to book

3.63

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.48

Employees

4

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Traws Pharma, Inc.

Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID-19 that are designed to address treatment resistance, such as TRX01 (Ratutrelvir), an inhibitor in development for the treatment of COVID-19; and Tivoxavir marboxil, an endonuclease inhibitor in development for the treatment of bird flu and seasonal influenza. It is also developing narazaciclib, a multi-targeted kinase inhibitor in solid tumors and hematological malignancies as a single agent or in combination with other anti-cancer therapies; and rigosertib, which is administered alone or in combination for investigation in various cancers. It has a license agreement with SymBio Pharmaceuticals Limited, Pint International SA, Viriom, Inc., Knight Therapeutics Inc., Specialised Therapeutics Asia Pte. Ltd., and Temple University. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Traws Pharma, Inc. and compare it with other stocks.